What is the long-term trend for Kiniksa Pharmaceuticals International, plc's price / earnings?

Over 2 years (2022 to 2025), Kiniksa Pharmaceuticals International, plc's price / earnings has grown at a 205.4% compound annual growth rate (CAGR), from 5.7× to 53×.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Kiniksa Pharmaceuticals International, plc KNSA Price / earnings

Price / earnings at other companies

Ligand PharmaceuticalsLGND

25.9×—

Catalyst PharmaceuticalCPRX

13.7×-1.3×

AlkermesALKS

38.6×+23.4×

Neurocrine BiosciencesNBIX

19.8×-16.3×

ALN

Alnylam PharmaceuticalsALNY

87.4×—

AmgenAMGN

24.3×-3.9×

Other financials

Income statement

See full

Revenue$214.3M+55.5%

Gross profit$193.5M+61.3%

Operating income$29.3M+121%

Net income$22.6M+165%

EPS (diluted)$0.27+145%

Balance sheet

See full

Cash & equivalents$190.0M+20.9%

Total debt$9.0M-9.0%

Total equity$605.7M+32.4%

Total assets$825.3M+37.7%

Cash flow

See full

Operating cash flow$50.2M+125%

CapEx$161.0K+62.6%

Free cash flow$50.0M+125%

Valuation

See full

Market cap$4.24B+128%

Enterprise value$4.06B+139%

P/S5.6×+1.8×

Profitability

See full

Gross margin89.3%+3.5pp

Operating margin12.4%+10.2pp

Net margin9.7%+7.6pp

FCF margin21.8%+12.2pp

Returns & leverage

See full

Return on equity13.7%+11.3pp

Debt / equity0×0.0×

Current ratio3.8×+0.1×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

market cap/net income=50.4×

Based on the most recent quarter.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's price / earnings?: Kiniksa Pharmaceuticals International, plc (KNSA) reported price / earnings of 50.4× in Q1 2026.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's price / earnings?: Over 2 years (2022 to 2025), Kiniksa Pharmaceuticals International, plc's price / earnings has grown at a 205.4% compound annual growth rate (CAGR), from 5.7× to 53×.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.